Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Claghorn-Lesem Research Clinic historically operated as an independent research site specializing in psychiatric and neuropsychiatric clinical trials (Phases I-III), participating in over 350 clinical trials including antipsychotic agents, treatments for agitation, and cognitive disorders. It was noted for early QTC studies in 2nd-generation antipsychotics and infusion capabilities for new therapies. It does not develop drugs or own programs but serves as a site for sponsored studies[5][7][8].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Claghorn-Lesem Research Clinic.